Contemporary Management of Median Arcuate Ligament Syndrome Provides Early Symptom Improvement†  by Columbo, Jesse A. et al.
Table. Outcomes of open and fenestrated endovascular aneurysm repair
(FEVAR) repair by risk strata
Risk strata Open, % (n ¼ 107) FEVAR, % (n ¼ 80) P
Low risk
Death 1 0 1
Complication
Cardiac 3 1 1
Pulmonary 12 5 .2
Renal 5 2 .4
Moderate risk
Death 7.5 8.7 .8
Complication
Cardiac 6 4 .3
Pulmonary 22 3 <.01
Renal 8 3 .1
High risk
Death 40 4 <.01
Complication
Cardiac 17 4 .2
Pulmonary 33 12 .07
Renal 26 4 .02
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Contemporary Management of Median Arcuate Ligament Syndrome
Provides Early Symptom Improvementy
Jesse A. Columbo, Thadeus L. Trus, Brian W. Nolan, Byron F. Santos
Aleman, Philip P. Goodney, Eva M. Rzucidlo, Richard J. Powell, Daniel
B. Walsh, David H. Stone. Dartmouth-Hitchcock Medical Center,
Lebanon, NH
Objectives: Optimal diagnosis and management of median arcuate lig-
ament syndrome (MALS) remains unclear in contemporary practice. The
advent and evolution of laparoscopic and endovascular techniques has redir-
ected management toward a less invasive therapeutic algorithm. This study
examined our contemporary outcomes of patients treated for MALS.
Methods: All patients treated for MALS at Dartmouth-Hitchcock
Medical Center from 2000 to 2013 were retrospectively reviewed. Demo-
graphics and comorbidities were recorded. Freedom from symptoms and
from reintervention were the primary end points. Functional quality of life
was assessed. Follow-up via clinic visits and telephone allowed quantitative
comparisons among patients.
Results: During the study interval, 21 patients (24% male), mean age,
37 years, were treated for MALS. All patients complained of abdominal pain
in the presence of a celiac stenosis, 17 (81%) reported weight loss at the time
of presentation, and 57% had a concomitant psychiatric history. Diagnostic
imaging most commonly used included duplex ultrasound (81%), computed
tomography angiography (66%), angiography (57%), and magnetic reso-
nance angiography (5%). All patients underwent initial laparoscopic MAL
release. Seven patients (33%) underwent subsequent celiac stent placement,
in the setting of recurrent or unresolved symptoms with persistent celiac ste-
nosis, at a mean interval of 49 days. Two patients required surgical bypass
after an endovascular intervention failed. At 6 months, freedom from symp-
toms was 73% and freedom from reintervention was 64%. Eighteen (81%)
patients reported early symptom improvement and weight gain, and 66%
were able to return to work.
Conclusions: A multidisciplinary treatment approach using initial
laparoscopic release and subsequent stent placement and bypass sur-
gery provides symptom improvement in most patients treated for
MALS. The potential placebo effect, however, remains uncertain. A
signiﬁcant minority of patients will require reintervention, justifying
longitudinal surveillance and better patient selection. Patients can
anticipate functional recovery, weight gain, and return to work with
treatment.
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Signiﬁcant Long-Term Predictors of Reintervention Following
Percutaneous Subclavian Artery Revascularization>
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Hass, John Campbell, Aravindra Nanjundappa, Mohit Srivastava, Patrick
Stone, Mark Bates, Ali AbuRahma. WestVirginiaUniversity,Charleston,WVa
Objectives: This study was conducted to determine long-term predic-
tors of reintervention after percutaneous subclavian artery revascularization
(PSAR).
Methods: This was a single-center retrospective review of patients
with a symptomatic subclavian artery who underwent PSAR between
January 1999 and December 2013. In-stent restenosis (ISR) was deﬁned
as stenosis $70% on duplex ultrasound and target vessel reintervention
(TVR) as the occurrence of a repeat intervention. Freedom from events
(ISR and TVR) was analyzed using Kaplan-Meier Curves. Cox regression
analysis was used to determine the signiﬁcant predictors of TVR and
restenosis.
Results: Of the 147 endovascular revascularization attempts, 145
were successful (98.6%). A total of 118 patients (76.3% female) received
initial subclavian interventions, and 19 (16.1%) required a secondary inter-
vention (at least one TVR), whereas eight required more than one reinter-
vention during the study period. Maximum follow up was 14.5 with a mean
6 standard error of the mean of 7.3 6 4.1 years. Patients were average ageyNew England Society for Vascular Surgery
>Eastern Vascular Societyof 64.1 years. Comorbidities included chronic hypertension (69.5%), dia-
betes (38.1%), peripheral vascular disease (25.4%), and tobacco use
(50.8%). Freedom from ISR and TVR at 1, 5, and 10 years was 93%,
83%, and 75%, and 94%, 87%, and 81%, respectively. Smoking increased
the likelihood of ISR (hazard ratio [HR], 5.3; 95% conﬁdence interval
[CI], 1.7-17.1; P ¼ .004), whereas the side of the intervention (right
side) and increased age at the time of the intervention (by decade) decreased
the likelihood of ISR (HR, 0.18; 95% CI, 0.03-0.83; P ¼ .028) and (HR,
0.50; 95% CI, 0.32-0.77; P ¼ .002), respectively. In the meantime, we
found that smoking increased the likelihood of TVR (HR, 3.1; 95% CI,
1.01-9.6; P ¼ .048), and that age (by decade) decreased the likelihood of
TVR (HR, 0.51l 95% CI, 0.32-0.82; P ¼ .006).
Conclusions: Percutaneous subclavian artery revascularizations are
feasible and durable, with satisfactory outcomes well beyond 10 years. Sec-
ondary interventions are common in smokers. Older age at onset and right
side disease were found to decrease the odds of ISR and TVR.
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Risk Stratiﬁed Analysis of Open Versus Fenestrated Repair of Complex
Abdominal Aortic Aneurysmsy
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Objectives: Commercial availability of fenestrated stent grafts for
endovascular aneurysm repair (FEVAR) in the United States has expanded
options for patients with complex (juxtarenal or suprarenal) abdominal
aortic aneurysms (CAAA). This study evaluated outcomes of open vs
FEVAR repair of CAAA using the National Surgical Quality Improvement
Project (NSQIP) database.
Methods: The NSQIP Participant Use File (2012) was queried by
Current Procedural Terminology codes to identify patients undergoing
open repair or FEVAR. A previously developed and validated risk scoring
system was revalidated using open and FEVAR patients. It was used to
assign CAAA patients into risk strata, and outcomes of open and FEVAR
repair were analyzed by patient risk.
Results: This study included 294 open and 165 FEVAR repairs.
FEVAR patients were older (76 6 9 vs 71 6 9 years; P < .01), had periph-
eral vascular disease (18% vs 7% 6 9%; P ¼ .03), and did not have rupture
(0% vs 19%; P < .01). FEVAR had shorter operating room time (2006 130
vs 270 6 130 minutes; P < .01) and median length of stay (3 vs 8 days; P <
.01). FEVAR conﬁgurations involved 0 (71%), 1 (8%), 2 (2%), or 3 (19%)
visceral stents. Our risk prediction model had excellent ﬁt to open andyNew England Society for Vascular Surgery
